Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 284

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 284
---
 A Preferred Stock. The equity value of the Common Stock underlying the Series A Preferred Stock is calculated using the greatest
closing sale price of the Common Stock on any trading day immediately preceding the date we notify the holders of our election to redeem
and the date we make the entire payment required.

Fundamental Transactions.
The Series A Certificate of Designations prohibit us from entering specified fundamental transactions (including, without limitation,
mergers, business combinations and similar transactions) unless we (or our successor) assumes in writing all of our obligations under
the Series A Certificate of Designations and the other Transaction Documents (as defined in the Series A Certificate of Designations).

Voting Rights. The
holders of the Series A Preferred Stock shall have no voting power and no right to vote on any matter at any time, either as a separate
series or class or together with any other series or class of share of capital stock, and shall not be entitled to call a meeting of
such holders for any purpose nor shall they be entitled to participate in any meeting of the holders of Common Stock, except as provided
in the Series A Certificate of Designations (or as otherwise required by applicable law).

Covenants. The Series
A Certificate of Designations contains a variety of obligations on our part not to engage in specified activities, which are typical
for transactions of this type. In particular, we will not, and will cause our subsidiaries to not, redeem, repurchase or declare any
dividend or distribution on any of our capital stock (other than as required under the Series A Certificate of Designations). In addition,
we will not issue any preferred stock or issue any other securities that would cause a breach or default under the Series A Certificate
of Designations or Structuring Warrants.

Reservation Requirements.
So long as any Series A Preferred Stock remains outstanding, we shall at all times reserve at least 150% of the number of shares of Common
Stock as shall from time to time be necessary to effect the conversion of all Series A Preferred Stock then outstanding.

Series B Convertible Preferred Stock

We designated 626 shares
of our authorized and unissued Preferred Stock as Series B Preferred Stock and established the rights, preferences and privileges of
the Series B Preferred Stock pursuant to the Series B Certificate of Designations filed with the Secretary of State of the State of Delaware,
as summarized below. Except as set forth below, the Series B Preferred Stock has terms and provisions that are identical to those of
the Series A Preferred Stock.

Ranking. The Series